Skip to main content
. Author manuscript; available in PMC: 2015 Mar 27.
Published in final edited form as: AIDS. 2014 Mar 27;28(6):831–840. doi: 10.1097/QAD.0000000000000145

Figure 1. Monocyte Phenotype by CAC Outcome.

Figure 1

After gating on live cells that express HLA-DR and lack expression of markers of T, B, and NK cells (CD2, CD3, CD19, CD20, and CD56), the proportions of monocytes expressing CD14 (horizontal axis) and CD16 (vertical axis) are shown for representative patients with: A) No CAC: absent at baseline and at year 2 follow up, B) Incident CAC: absent at baseline but detectable at year 2 follow up, C) Stable CAC: detectable at baseline but without significant increase over 2 years of follow up, and D) Increased CAC: detectable at baseline with a significant increase over 2 years of follow up. The percent of cells for each quadrant are reported in the outer most corner. Greater frequencies of CD14+/CD16+ (upper right quadrant) and CD14var/CD16+ (both upper quadrants combined) are seen with subsequent CAC progression (‘B’ and ‘D’).